Sarepta’s Elevidys will remain on the market with a black box warning. But this gene therapy for Duchenne muscular dystrophy still faces commercial headwinds and analysts say the company has work to do to win over patients and investors. The post Sarepta Slashes Staff, Maps Path Forward for Gene Therapy and Narrower Pipeline appeared first…
[Sponsored] A report by Paubox maintains that many compliance failures are caused by false assumptions rather than negligence. The post 5 Email Security Misconceptions That Put Healthcare Organizations at Risk appeared first on MedCity News.
Without systemic redesign, these efforts risk reinforcing the same pain points that made prior authorization a flashpoint for payers and providers. The post CMS and AHIP Isn’t the Finish Line: It’s the Starting Gun for Prior Auth Innovation appeared first on MedCity News.
While this kind of innovation and change can be challenging and is often a significant investment, it represents a powerful combination that can benefit individuals, healthcare professionals, and laboratories. The post Two Imperatives for the Future of Diagnostics: Adaptability and Digitalization to Unlock the Potential of AI appeared first on MedCity News.
Fourteen investors have committed to offering office hours at the HW Venture Center in July and August. The post Health Wildcatters Launches HW Venture Center to Foster Investor-Startup Matchmaking appeared first on MedCity News.
CalPERS has entered into a five-year agreement with CVS Caremark, who will provide outpatient prescription drug benefits for about 587,000 members enrolled in basic or Medicare HMO or PPO plans. The post CalPERS Selects CVS Caremark as PBM, Replacing OptumRx appeared first on MedCity News.
Healthcare providers are making cybersecurity progress, but serious vulnerabilities remain — especially when it comes to AI governance, third-party risk, and limited budgets. Fortified Health Security CEO Dan Dodson urged the industry to stop waiting for perfect conditions and act decisively to strengthen their defenses. The post Despite Progress, Healthcare Cybersecurity Is Still Falling Short…
Though anselamimab failed its Phase 3 test in light chain amyloidosis, AstraZeneca points to encouraging results in a pre-defined patient subgroup — which may not be a winning strategy. Prothena resurrected its failed drug candidate for the disease based on a subgroup analysis, only to see that antibody fall short in a pivotal study. The…
The transformation of our healthcare system can start now, with employers adopting value-based care models, communities demanding better access, and policymakers challenging the status quo. The post The Crisis That Unites Us: Healthcare Costs Are Breaking Everyone appeared first on MedCity News.
This is more than a missed opportunity. It’s a growing liability financially, operationally, and culturally. Men’s health must be redefined not just as a clinical issue, but as a strategic business lever. The post Men’s Health is an Overlooked Part of Family Health: Why Employers Should Rethink Their Benefits Strategy appeared first on MedCity News.